ATGAM;
Showing 1 - 25 of 55
ATGAM General Investigation
Not yet recruiting
- Aplastic Anemia
- Anti-human thymocyte immunoglobulin, equine
- (no location specified)
Sep 8, 2023
Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Stem cell infusion
- +5 more
-
Saint Louis, MissouriWashington University
Jan 17, 2023
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Crohn Disease Trial in Los Angeles (drug, procedure, biological)
Recruiting
- Crohn Disease
- Mesna
- +12 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 23, 2022
Refractory Non Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma Trial in Sacramento (biological, radiation, procedure, drug)
Active, not recruiting
- Refractory Non Hodgkin Lymphoma
- Relapsed Non Hodgkin Lymphoma
- rituximab
- +7 more
-
Sacramento, CaliforniaUniversity of California Davis
Nov 28, 2022
Severe Aplastic Anemia Trial in Paris (ATGAM plus CsA with or without Eltrombopag)
Enrolling by invitation
- Severe Aplastic Anemia
- ATGAM plus CsA with or without Eltrombopag
-
Paris, FranceHospital St. Louis
Sep 21, 2021
Anemia, Aplastic, Anemia, Hypoplastic Trial run by the NHLBI (h-ATG (ATGAM ), Cyclosporine (Gengraf ))
Completed
- Anemia, Aplastic
- Anemia, Hypoplastic
- h-ATG (ATGAM )
- Cyclosporine (Gengraf )
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 1, 2021
Severe Aplastic Anemia Trial in United States (drug, procedure, radiation)
Active, not recruiting
- Severe Aplastic Anemia
- cyclosporine
- +8 more
-
Los Angeles, California
- +12 more
Feb 10, 2022
Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Active, not recruiting
- Adult Acute Lymphoblastic Leukemia in Remission
- +14 more
- radiation therapy
- +8 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Oct 7, 2022
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy Trial in United States (High-dose methylprednisolone,
Recruiting
- Acute Liver Failure
- +4 more
- High-dose methylprednisolone
- +6 more
-
Los Angeles, California
- +19 more
Dec 5, 2022
Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)
Terminated
- Leukemia, Myeloid, Chronic
- +8 more
- Stem Cell Transplant
- +5 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 31, 2020
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,
Recruiting
- Aplastic Anemia
- +3 more
- Anti-Thymocyte Globulin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Dec 1, 2021
Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)
Completed
- Myeloproliferative Disorders
- +3 more
- anti-thymocyte globulin
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Oct 30, 2020
Acute Myeloid Leukemia, B-Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Stanford (biological, drug,
Completed
- Acute Myeloid Leukemia
- +6 more
- Anti-Thymocyte Globulin
- +5 more
-
Stanford, CaliforniaStanford University, School of Medicine
Jun 1, 2021
Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia Trial in Cleveland (radiation, drug, procedure,
Completed
- Acute Myeloid Leukemia
- +10 more
- total marrow irradiation
- +7 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Seidman Cancer Ce
May 5, 2021
Aplastic Anemia, Hypoplastic Myelodysplastic Syndrome Trial in Houston (BL-8040, horse anti-thymocyte globulin (hATG),
Completed
- Aplastic Anemia
- Hypoplastic Myelodysplastic Syndrome
- BL-8040
- +3 more
-
Houston, TexasMD Anderson Cancer Center
Dec 28, 2020
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell
Completed
- Acute Lymphoblastic Leukemia in Remission
- +6 more
- Allogeneic Bone Marrow Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Dec 15, 2021
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Non-Neoplastic Hematologic and Lymphocytic Disorder Trial in United States (procedure, biological, drug, other, radiation)
Completed
- Non-Neoplastic Hematologic and Lymphocytic Disorder
- Allogeneic Bone Marrow Transplantation
- +11 more
-
Aurora, Colorado
- +5 more
Jul 21, 2021
Scleroderma, Systemic, Sclerosis, Autoimmune Disease Trial in Canada, United States (mHSCT, cyclophosphamide)
Completed
- Scleroderma, Systemic
- +2 more
- mHSCT
- cyclophosphamide
-
Duarte, California
- +16 more
May 12, 2021